Journal of Oncology / 2019 / Article / Tab 1

Research Article

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Table 1

Patients’ characteristics.

No. (%)

Total number159 pts

Age

<5040 (25.2)
50119 (74.8)

Tumor samples

Primary159 (100)
Metastasis24 (15.1)
Both24 (15.1)

T at diagnosis

173 (50.0)
256 (38.4)
35 (3.4)
412 (8.2)
Unknown13

N at diagnosis

059 (41.8)
152 (36.9)
214 (9.9)
316 (11.4)
Unknown18

M at diagnosis

0122 (76.7)
137 (23.3)

Grade

16 (4.8)
248 (38.1)
372 (57.1)
Unknown33

Adjuvant systemic therapy

No adjuvant therapy12 (7.5)
Chemotherapy84 (52.8)
Hormone therapy84 (52.8)
Both58 (36.5)
Unknown37 (23.3)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.